Press Releases

Jiangsu Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma" or the "Company") once again had five high-quality drugs successfully selected in the f...

Official Release Hansoh Pharmaceutical Group Company Limited ("Hansoh Pharma" or the "Company") has received approval from the National Medical Produc...

Recently, Jiangsu Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma" or the "Company") won the honorary title of "Science and Technology Innovatio...

"Efficacy and Safety of Almonertinib Mesilate VS Platinum-Containing Dual-Agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic...

From June 4 to 8, the 2021 Annual Meeting of American Society of Clinical Oncology (ASCO), the world's leading academic organization for oncology, was...

Recently, the clinical trial application of Jiangsu Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma" or the "Company") for HS-20094, an independ...

The American Society of Clinical Oncology (ASCO) Annual Meeting is the world's most authoritative academic exchange event in the field of oncology. Th...

Recently, Jiangsu Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma" or "Company") received the Notice of Approval for Clinical Trial of Drug from...